Health care professionals recommend Palbociclib for patients suffering from HR-positive, HER2-negative advanced, or metastatic breast cancer. Palbociclib is sold under the trade name Ibrance. It is a cyclin-dependent kinase(a protein kinase that helps regulate cell cycle and transcription, mRNA processing, and the differentiation of nerve cells) inhibitor. Inactive ingredients of the medicine are Microcrystalline cellulose, lactose monohydrate, sodium starch glycolate, colloidal silicon dioxide, magnesium stearate.
It comes in a strength of 125 mg. Palbociclib 125 mg general dosage is a tablet of 125 mg taken orally once a day in a row of 21 days followed by 7 days without the treatment to comprise a complete cycle of 28 days. Dosage is accepted only under the supervision of the doctor. Fatigue, nausea, hair fall, skin rash, fever, infection, etc., are the common side effects of the medicine.
There are some rare and fatal side effects of the Palbociclib 125 mg tablet: decreased levels of specific blood cells, such as red blood cells, white blood cells, platelets, inflammation (swelling), or scarring in your lungs, and allergic reaction.
Palbociclib medicine is readily available in India. To buy such rare drugs, one should always go for certified suppliers in supplying services. One such trusted supplier in India is Ikris Pharma Network, delivering medicines and services in India and overseas. Palbociclib cost is also cheaper in India than the cost offered by the innovators.